WEST PHARMACEUTICAL SERVICES, INC. (WST) Return on Tangible Equity

WEST PHARMACEUTICAL SERVICES INC Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

• WEST PHARMACEUTICAL SERVICES INC return tang equity for the quarter ending 2020-03-31 was 19.25%, a 9.52% increase year-over-year.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for the quarter ending 2019-12-31 was 16.84%, a 3.36% increase year-over-year.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for the quarter ending 2019-09-30 was 16.89%, a 33.43% increase year-over-year.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for the quarter ending 2019-06-30 was 17.37%, a 32.97% increase year-over-year.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for fiscal 2019 was 16.84%, a 3.36% increase from fiscal 2018.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for fiscal 2018 was 16.29%, a 24.35% increase from fiscal 2017.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for fiscal 2017 was 13.10%, a 9.59% decline from fiscal 2016.
• WEST PHARMACEUTICAL SERVICES INC return tang equity for fiscal 2016 was 14.49%, a 33.62% increase from fiscal 2015.